)
TruBridge (TBRG) investor relations material
TruBridge EGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Opening remarks and agenda
Meeting held virtually to maximize accessibility and reduce environmental impact.
Recognition of board members and key officers in attendance.
Agenda included two main proposals: merger agreement and executive compensation.
Specific resolutions to be voted on
Approval of the agreement and plan of merger for the company to become a subsidiary of IKS.
Advisory vote on compensation for named executive officers related to the merger.
Corporate governance
Proper notice of meeting and proxy statement distribution confirmed.
Quorum established with over 50% of outstanding shares represented.
Independent inspector of election appointed to oversee voting.
- Demand, bookings, and margins are rising as offshoring and automation drive operational gains.TBRG
Stephens 26th Annual Investment Conference | NASH2024 - Shareholders to vote on a premium cash merger with IKS; board and major holders support the deal.TBRG
Proxy filing - Shareholders to vote on cash merger at $26.25/share; board and major holders support the deal.TBRG
Proxy filing - Q1 2026 saw $86.3M revenue, rising non-GAAP net income, and a pending IKS acquisition.TBRG
Q1 2026 - TruBridge's acquisition by IKS Health targets improved healthcare access and operational stability.TBRG
Proxy filing - IKS Health to acquire TruBridge for $557M, creating a leading healthcare solutions platform.TBRG
Proxy filing - TruBridge will be acquired by IKS for $26.25 per share in cash, pending approvals.TBRG
Proxy filing - Margin gains, strong recurring revenue, and GAAP profitability marked the year.TBRG
Q4 2025 - RCM growth and margin gains offset EHR declines as net loss widens and 2024 guidance is reaffirmed.TBRG
Q2 2024
)
)
)
)
)
)
)
)